x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Heart Matters

Since cardiovascular disease is one of the leading causes of death in the U.S., cardiology physicians are continuously working to better understand this common disease and to help patients improve their heart health. And here to assist cardiology physicians in this mission is Heart Matters, a series dedicated to covering essential strategies and research efforts focusing on all types of heart problems, including coronary artery diseases, heart attacks, high cholesterol, high blood pressure, and

science & medicine medicine

All Episodes

00:00:00

Targeting Anemia, Iron Deficiency for Patients With...

Heart Matters ·

2009/12/09

Host: Alfred Bove, MD Guest: William Dec, MD Correcting anemia or iron deficiency in patients with heart failure has been shown to improve mortality and quality of life. Among patients with heart failure, how common are anemia and iron deficiency? What type of iron supplementation therapy is most effective? Dr. William Dec, chief of the cardiology division, co-director of the Massachusetts General Hospital Heart Center, and the Roman W. DeSanctis Professor of Medicine at Harvard

en

00:00:00

Targeting Anemia, Iron Deficiency for Patients With...

Heart Matters ·

2009/12/09

Host: Alfred Bove, MD Guest: William Dec, MD Correcting anemia or iron deficiency in patients with heart failure has been shown to improve mortality and quality of life. Among patients with heart failure, how common are anemia and iron deficiency? What type of iron supplementation therapy is most effective? Dr. William Dec, chief of the cardiology division, co-director of the Massachusetts General Hospital Heart Center, and the Roman W. DeSanctis Professor of Medicine at Harvard

en

00:00:00

The Challenges of Defibrillator and Pacemaker Lead...

Heart Matters ·

2009/12/09

Host: Alfred Bove, MD Guest: Charles Love, MD Defibrillator and pacemaker leads can be challenging to remove or replace, even when the procedure is performed by an experienced cardiologist. Infection, manufacturer recall and device malfunction are all reasons a lead might require extraction. How can we balance the risks of the procedure with the potential harms of leaving a lead implanted? Dr. Charles Love, professor of clinical medicine in the division of cardiovascular medicine

en

00:00:00

The Challenges of Defibrillator and Pacemaker Lead...

Heart Matters ·

2009/12/09

Host: Alfred Bove, MD Guest: Charles Love, MD Defibrillator and pacemaker leads can be challenging to remove or replace, even when the procedure is performed by an experienced cardiologist. Infection, manufacturer recall and device malfunction are all reasons a lead might require extraction. How can we balance the risks of the procedure with the potential harms of leaving a lead implanted? Dr. Charles Love, professor of clinical medicine in the division of cardiovascular medicine

en

00:00:00

The ARBITER 6-HALTS Trial: Clinical Implications

Heart Matters ·

2009/11/18

Host: Jack Lewin, MD Guest: Christopher Cannon, MD Previous trials, including the ENHANCE trial, have raised doubts about the clinical benefits of adding ezetimibe to high-dose statin therapy. The ARBITER 6-HALTS trial added further weight to the results of ENHANCE, wherein the ARBITER trial demonstrated that extended-release niacin was superior to ezetimibe as adjunctive therapy to high-dose statins in slowing atherosclerosis. However, this study was not based on clinical

en

00:00:00

The Advantages of a Collaborative Cardiac Care Model

Heart Matters ·

2009/11/18

Host: Jack Lewin, MD Guest: George Halvorson How does an integrated cardiac care model work, and how difficult a process is such a model to implement? What are the various components of the program, and what have the results been? George Halvorson, chairman and chief executive officer of Kaiser Permanente and author of the book Healthcare Will Not Reform Itself, joins host Dr. Jack Lewin to discuss the advantages of a collaborative care model and the importance of efficient data

en

00:00:00

The Advantages of a Collaborative Cardiac Care Model

Heart Matters ·

2009/11/18

Guest: George Halvorson Host: Jack Lewin, MD How does an integrated cardiac care model work, and how difficult a process is such a model to implement? What are the various components of the program, and what have the results been? George Halvorson, chairman and chief executive officer of Kaiser Permanente and author of the book Healthcare Will Not Reform Itself, joins host Dr. Jack Lewin to discuss the advantages of a collaborative care model and the importance of efficient data

en

00:00:00

Troponin Assays for Diagnosing Myocardial Infarction

Heart Matters ·

2009/11/09

Host: Janet Wright, MD Guest: David Morrow, MD, MPH Standard troponin assays can be a crucial tool in diagnosing myocardial infarction, but have also been criticized for their low specificity at the time of presentation. Will newer, more sensitive troponin assays improve early detection and diagnostic accuracy for MI? Even with use of the newer assays, Dr. David Morrow, associate professor of medicine at Harvard Medical School, warns that elevated troponin may not necessarily

en

00:00:00

Troponin Assays for Diagnosing Myocardial Infarction

Heart Matters ·

2009/11/09

Guest: David Morrow, MD, MPH Host: Janet Wright, MD Standard troponin assays can be a crucial tool in diagnosing myocardial infarction, but have also been criticized for their low specificity at the time of presentation. Will newer, more sensitive troponin assays improve early detection and diagnostic accuracy for MI? Even with use of the newer assays, Dr. David Morrow, associate professor of medicine at Harvard Medical School, warns that elevated troponin may not necessarily

en

00:00:00

New Recommendations for STEMI and PCI

Heart Matters ·

2009/11/09

Host: Janet Wright, MD Guest: Judith Hochman, MD What are the 2009 recommendations for best managing ST-segment-elevation myocardial infarction, or STEMI, and the need for percutaneous coronary intervention, or PCI? Dr. Judith Hochman, the Harold Snyder Family Professor of Cardiology and clinical chief of cardiology at the New York University (NYU)-New York City Health and Hospitals Corporation (HHC) Clinical Translational Science Institute, reviews the most significant components

en

00:00:00

New Recommendations for STEMI and PCI

Heart Matters ·

2009/11/09

Host: Janet Wright, MD Guest: Judith Hochman, MD What are the 2009 recommendations for best managing ST-segment-elevation myocardial infarction, or STEMI, and the need for percutaneous coronary intervention, or PCI? Dr. Judith Hochman, the Harold Snyder Family Professor of Cardiology and clinical chief of cardiology at the New York University (NYU)-New York City Health and Hospitals Corporation (HHC) Clinical Translational Science Institute, reviews the most significant components

en

00:00:00

The Role of Cardiac Resynchronization in the...

Heart Matters ·

2009/10/26

Host: Janet Wright, MD Guest: Arthur Moss, MD Although cardiac resynchronization therapy (CRT) is recommended for patients with moderate to severe heart failure and a prolonged QRS interval, is it ever recommended for patients with mild cardiac symptoms? Can prophylactic resynchronization therapy, delivered by an implantable defibrillator, reduce the risk of heart failure or death in those patients with mild cardiac sympotoms? Tune in to hear Dr. Arthur Moss, professor of medicine

en

00:00:00

The Role of Cardiac Resynchronization in the...

Heart Matters ·

2009/10/26

Host: Janet Wright, MD Guest: Arthur Moss, MD Although cardiac resynchronization therapy (CRT) is recommended for patients with moderate to severe heart failure and a prolonged QRS interval, is it ever recommended for patients with mild cardiac symptoms? Can prophylactic resynchronization therapy, delivered by an implantable defibrillator, reduce the risk of heart failure or death in those patients with mild cardiac sympotoms? Tune in to hear Dr. Arthur Moss, professor of medicine

en

00:00:00

The Hypertension Paradox: Better Treatment, Worse...

Heart Matters ·

2009/10/26

Host: Janet Wright, MD Guest: Aram Chobanian, MD In recent years, we have developed a sufficient understanding of the mechanisms behind hypertension that has led to the evolution of numerous diagnostic and treatment options. Yet the prevalence of hypertension persists. Why does hypertension continue to disable and kill millions throughout the world, and what can we do to reduce the incidence of this chronic condition? Dr. Aram Chobanian, president emeritus of Boston University, who

en

00:00:00

The Hypertension Paradox: Better Treatment, Worse...

Heart Matters ·

2009/10/26

Host: Janet Wright, MD Guest: Aram Chobanian, MD In recent years, we have developed a sufficient understanding of the mechanisms behind hypertension that has led to the evolution of numerous diagnostic and treatment options. Yet the prevalence of hypertension persists. Why does hypertension continue to disable and kill millions throughout the world, and what can we do to reduce the incidence of this chronic condition? Dr. Aram Chobanian, president emeritus of Boston University, who

en

00:00:00

Pediatric Heart Disease: The Need for More Rigorous...

Heart Matters ·

2009/10/26

Host: Janet Wright, MD Guest: Gerard R. Martin, MD Although congenital heart disease is one of the most common birth defects, its complexity has made the accumulation of an evidence base a challenge. The IMPACT registry, which stands for improving pediatric and adult congenital treatments, has been created to fill this information gap, and it is hoped that these data will provide clinical evidence to help guide treatment for pediatric heart disease. Dr. Gerard Martin, senior vice

en

00:00:00

Pediatric Heart Disease: The Need for More Rigorous...

Heart Matters ·

2009/10/26

Host: Janet Wright, MD Guest: Gerard R. Martin, MD Although congenital heart disease is one of the most common birth defects, its complexity has made the accumulation of an evidence base a challenge. The IMPACT registry, which stands for improving pediatric and adult congenital treatments, has been created to fill this information gap, and it is hoped that these data will provide clinical evidence to help guide treatment for pediatric heart disease. Dr. Gerard Martin, senior vice

en

00:00:00

When Patients Leave the Hospital, a Healthier Transition

Heart Matters ·

2009/09/24

Host: Jack Lewin, MD Guest: Donald Berwick, MD, MPP There are several prominent points of disagreement in today's health reform debate, but one area of general accord involves hospital readmissions: we can (and must) do much better in coordinating the transition and follow-up process for admissions and readmissions — and, if executed properly, this will improve outcomes for our patients. As we embark on a campaign to reduce unnecessary readmissions, Dr. Donald M. Berwick, president

en

00:00:00

When Patients Leave the Hospital, a Healthier Transition

Heart Matters ·

2009/09/24

Host: Jack Lewin, MD Guest: Donald Berwick, MD, MPP There are several prominent points of disagreement in today's health reform debate, but one area of general accord involves hospital readmissions: we can (and must) do much better in coordinating the transition and follow-up process for admissions and readmissions — and, if executed properly, this will improve outcomes for our patients. As we embark on a campaign to reduce unnecessary readmissions, Dr. Donald M. Berwick, president

en

00:00:00

My Heart Your Heart: Explanting Pacemakers to Reuse...

Heart Matters ·

2009/09/17

Host: Janet Wright, MD Guest: Timir Baman, MD Charitable organizations have been working for years to support the harvesting of pacemakers for implantation in individuals worldwide, for whom these lifesaving and life-prolonging devices otherwise might not be available. It is a practice that is not currently allowed for reuse within the United States, on the grounds that it has not been proven safe and effective. A team of investigators at the University of Michigan, as part of the

en

320 results

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事